Month: April 2021

NEXITY LANCE UNE EMISSION D’OBLIGATIONS CONVERTIBLES EN ACTIONS NOUVELLES ET/OU ECHANGEABLES EN ACTIONS EXISTANTES (OCEANE) A ECHEANCE 2028 POUR UN MONTANT MAXIMUM D’ENVIRON 270 M€ ET UNE OFFRE CONCOMITANTE DE RACHAT DES OCEANE EXISTANTES A ECHEANCE 2023 EMISES EN MAI 2016 PAR L’INTERMEDIAIRE D’UNE PROCEDURE DE CONSTRUCTION D’UN LIVRE D’ORDRES INVERSE Paris, le 13 avril 2021 Emission d’obligations convertibles en actions nouvelles et/ou échangeables en actions existantes à échéance le 19 avril 2028 (les « OCEANE 2028 » ou les « Obligations ») (sous condition suspensive de la réception de marques d’intérêt vendeurs suffisantes dans le cadre du Rachat concomitant (comme défini ci-dessous) de la part des porteurs d’OCEANE 2023 (comme défini ci-dessous) portant sur au moins 60% du nombre d’OCEANE 2023 (comme défini ci-dessous) émises...

Oslo, Norway – 13 April 2021 – IDEX Biometrics ASA (OSE: IDEX and Nasdaq: IDBA), a leading provider of advanced fingerprint identification and authentication solutions, has been listed at the Nasdaq Capital Market in New York since 1 March 2021. To coordinate financial calendars and time of disclosures of Norway annual report and U.S. Form 20-F, as well as the notice of the 2021 annual general meeting, the documents will be published on Wednesday 21 April 2021. The company confirms that the 2020 annual financial statements will be consistent with the preliminary financial statements for 2020 that were issued on 25 February 2021. For further information contact:Marianne Bøe, Investor RelationsE-mail: marianne.boe@idexbiometrics.comTel: + 47 9180 0186 Derek D’Antilio, Chief Financial OfficerE-mail: derek.dantilio@idexbiometrics.comTel:...

OSLO Norway (13 April 2021) – Based on preliminary reporting from operating units, TGS management expects net IFRS revenues* for the first quarter of 2021 to be approximately USD 186 million, up from USD 52 million in Q1 2020. Net segment revenues* are expected to be approximately USD 75 million, compared to USD 152 million in Q1 2020. Kristian Johansen, CEO at TGS, stated, “As expected the challenging market conditions continued in Q1 2021. However, we remain cautiously optimistic for the remainder of the year, with the higher oil prices expected to result in higher activity level in the latter part of the year. Furthermore, I am pleased to note that we continue to outperform our cost expectations, which together with relatively low investments of approximately USD 37 million, resulted in a solid free cash flow and a cash balance...

Issy-les-Moulineaux, April 13, 2021 – Sodexo Inc, the US subsidiary of Sodexo, world leader in Quality of Life services, has successfully completed yesterday a bond issue for a total principal amount of $1.25 billion in two tranches: $500 million due April 2026 with a coupon of 1.634% and $750 million due April 2031 with a coupon of 2.718%. This transaction is Sodexo Inc’s inaugural US dollar bond offering. Sodexo Inc will use the net proceeds for general corporate purposes. The bonds are guaranteed by Sodexo SA, the parent company of the Sodexo group.   About Sodexo Founded in Marseille in 1966 by Pierre Bellon, Sodexo is the global leader in services that improve Quality of Life, an essential factor in individual and organizational performance. Operating in 64 countries, Sodexo serves 100 million consumers each day through its...

Issy-les-Moulineaux, le 13 avril 2021 – Sodexo Inc, la filiale américaine de Sodexo, leader mondial des services de Qualité de Vie, a émis hier avec succès un emprunt obligataire d’un montant total de 1,25 milliard $ en deux tranches : 500 millions $ à échéance avril 2026, avec un coupon de 1,634%, et 750 millions $ à échéance avril 2031, avec un coupon de 2,718%. Cette opération est la première émission d’obligations en dollars américains de Sodexo Inc. Sodexo Inc utilisera le produit net de l’émission pour les besoins généraux du Groupe. Les obligations sont garanties par Sodexo SA, la société mère du groupe Sodexo. À propos de Sodexo Créé en 1966 à Marseille par Pierre Bellon, Sodexo est le leader mondial des services pour améliorer la Qualité de Vie, facteur essentiel de performance des individus et des organisations. Présent...

This is a joint press release by Sanofi Foreign Participations B.V. (the “Offeror”), Sanofi (“Sanofi”) and Kiadis Pharma N.V. (“Kiadis”), pursuant to the provisions of Article 16, paragraph 1 and 2 and Article 17 paragraph 1 of the Netherlands Decree in Public Takeover Bids (Besluit openbare biedingen Wft, the “Decree”) in connection with the intended public offer by the Offeror for all the issued and outstanding ordinary shares in the capital of Kiadis (the “Offer”). This announcement does not constitute an offer, or any solicitation of any offer, to buy or subscribe for any securities. Any offer will be made only by means of the offer memorandum dated 10 February 2021 (the “Offer Memorandum”), approved by the Dutch Authority for the Financial Markets (Autoriteit Financiële Markten) on 10 February 2021 and recognized by the Belgian Authority...

●  Xolair for self-injection offers healthcare providers and appropriate patients another administration option for more flexibility in managing their treatment Basel, 13 April 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s supplemental Biologics License Application for Xolair® (omalizumab) prefilled syringe for self-injection across all approved U.S. indications.1 Xolair is the only FDA-approved biologic designed to target and block immunoglobulin E (IgE) for the treatment of moderate to severe persistent allergic asthma, chronic idiopathic urticaria (CIU) and nasal polyps. “Today’s approval reflects our commitment to continued innovation with Xolair to address the critical needs of people living with allergic and inflammatory conditions,”...

Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 13 April 2021 – 7.00 am CET Fagron realizes turnover of € 134.8 million Strong operational performance in Latin and North America Highlights of Q1-2021Reported turnover decreased 4.8% on sharply weaker BRL, USD and MXN versus EUR Turnover growth of 4.9% at constant exchange rates Strong operational performance in North and Latin America despite fewer doctor’s visits and postponement of elective care Strong COVID-19 related decrease of prescriptions impacted performance in EMEA Wichita compounding facility on track; successful product launches offset lower demand due to COVID-19 Transition to new repackaging facility in Poland to start in second half of AprilRafael Padilla, CEO of Fagron: “As expected, the entire first quarter of 2021 was affected by far-reaching...

Gereglementeerde informatieNazareth (België)/Rotterdam (Nederland), 13 april 2021 – 7am CET Fagron boekt omzet van € 134,8 miljoen Sterke operationele performance in Latijns- en Noord- Amerika Kernpunten Q1-2021Forse verzwakking BRL, USD en MXN ten opzichte van EUR zorgen voor gerapporteerde omzetdaling van 4,8% ten opzichte van het eerste kwartaal van 2020 Omzetgroei van 4,9% tegen constante wisselkoersen Sterke operationele performance in Noord- en Latijns-Amerika ondanks uitstel niet kritische zorg en minder doktersbezoeken Sterke COVID-19-gerelateerde daling van aantal voorschriften heeft impact op performance in EMEA Bereidingsfaciliteit Wichita op koers; succesvolle productintroducties compenseren lagere vraag door COVID-19 Transitie naar nieuwe herverpakkingsfaciliteit in Polen in tweede helft van april van startRafael Padilla,...

SIKA EXPLOITS FURTHER GROWTH POTENTIAL IN QATAR In Qatar, Sika has expanded its production capacity for concrete admixtures and has started manufacturing epoxy resins. Epoxy resins are key components in high-quality floor coverings and adhesives. With its enlarged portfolio and its local production capacity, Sika wants to exploit market potential and drive forward the focused expansion of its business in the region. This latest investment in expansion in Qatar’s capital, Doha, will help Sika to continue building its business in this fast-growing region so that it can benefit from the dynamic development in the construction market. The sector is being boosted in particular by major projects and for the expansion of energy and utilities infrastructure, as well as stimuli induced by government tenders. Thanks to its local production facilities,...